Anti-cll-1 antibodies and uses thereof

An isolated anti-CLL-1 antibody or an antigen-binding fragment thereof comprising:

• (a) a VH CDR1 comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:
• 1, 2 and 3;
• (b) a VH CDR2 comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:
• 4, 5 and 6;
• (c) a VH CDR3 comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:
• 7, 8, 9, 10 and 11;
• (d) a VL CDR1 comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:
• 12, 13, 14 and 15;
• (e) a VL CDR2 comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:
• 16, 17 and 18;
• and
• (f) a VL CDR3 comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:
• 19, 20, 21 and 22.